 Home > Chemicals Industry > China Chemical > In search of sustainable growth internally and externally, the international competitiveness of the pharmaceutical industry is continuously strengthened

In search of sustainable growth internally and externally, the international competitiveness of the pharmaceutical industry is continuously strengthened

 Last Update: 2021-12-07
 Source: Internet
 Author: User

Tags

network model

serum total protein

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Hot attention from Chemical Machinery and Equipment Network ] Since the beginning of 2021, the performance of pharmaceutical companies has continued to release.
Looking forward to 2022, the endogenous growth of the pharmaceutical industry may remain strong, and companies need to improve both internally and externally to find sustainable and rapid growth
.
According to the industry, the international competitiveness of the pharmaceutical industry is constantly increasing, and many companies have gained clear international competitiveness through their own years of accumulation
.

Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipment

Pharmaceutical service companies accelerate the process of internationalization

According to the industry, companies in the direction of CDMO, relying on China's resource endowment advantages and their own accumulation for many years, have clear international competitiveness and are generally on the track of sustained and rapid growth
.
"We are strategically optimistic about the global rising trend and investment value of the advanced pharmaceutical manufacturing sector composed of the above-mentioned fields
.
"

Take Tigermed as an example, its global network layout is accelerating
.
Data show that as of 2021H1, Tigermed's overseas employees have increased from 772 at the end of 2020 to 854; a total of 140 operating projects are carried out overseas, of which 111 are single-regional trials and 29 are multi-regional clinical trials
.
In 2021, the company will continue to expand clinical operations and project management teams in major overseas markets (including the United States and Europe), and accelerate the establishment of a global service network.
At present, the heads of Europe and Latin America are in place
.

　　Analysts pointed out that considering the continuous increase in the international demand of local innovative drug companies, and with the continuous improvement of Tigermed's overseas service network, the number of overseas operating projects of the company still has a large room for improvement
.

　　More and more innovative pharmaceutical companies are taking steps to internationalize

　　The domestic sector of innovative drugs is in a period of rapid fulfillment, and the number of domestic innovative drugs approved has increased significantly every year
.
Nowadays, more and more innovative pharmaceutical companies have taken the steps of internationalization and have become the core indicator of the market to test the capabilities of innovative pharmaceutical companies
.

　　For example, on November 15th, Beijing Biomedical High-tech Company Nuocheng Jianhua disclosed that its self-developed new protein tyrosine phosphatase SHP2 allosteric inhibitor ICP-189 was approved by the US Food and Drug Administration for clinical research
.
This has also become Nuocheng Jianhua's fourth innovative drug approved for clinical use in the United States
.

　　Another example is Hengrui Pharmaceuticals recently stated that the company continues to increase its investment in internationalization.
At present, it has established professional clinical research and development teams in the United States, Europe, Australia, and Japan.
More than 100 overseas clinical research and development talents have joined the GPT) model, which has significantly improved the efficiency and quality of Hengrui International's clinical research
.
This means that Hengrui Medicine has taken substantial steps in its internationalization strategy
.

　　my country strongly promotes Chinese medicine "going out"

　　Recently, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-Quality Development of the Pharmaceutical Circulation Industry during the "14th Five-Year Plan" period", calling for the promotion of foreign exchanges and cooperation, proposing to vigorously develop the foreign trade of Chinese medicine, and expand the scale of the international market for Chinese medicine products
.

　　It is understood that in promoting the "going global" of Chinese medicine, many places continue to make efforts.
For example, Beijing will improve the international service system of Chinese medicine, build an international service platform for Chinese medicine, promote the internationalization of Chinese medicine projects, and cultivate Chinese medicine.
New business formats and new models of service export, exploring and advancing remote service models such as "Internet + Chinese medicine service", and enhancing the overall level and international status of Chinese medicine service trade
.

　　According to the industry, with the continuous strengthening of international cooperation and the accelerated development of world service trade, the internationalization of Chinese medicine in China is expected to enter the fast lane
.

　　However, it is worth mentioning that due to the constraints of cultural differences between China and the West, the internationalization of Chinese medicine lacks legal and institutional guarantees, and it is difficult for domestic standards to integrate with international standards.
The internationalization of Chinese medicine is still a long-term and complex project.
Make all efforts to enhance the competitiveness of the industry
.

　　Original title: Looking for sustainable growth internally and externally, the international competitiveness of the pharmaceutical industry continues to strengthen

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.